11 results
8-K
EX-10.1
NMTRQ
9 Meters Biopharma, Inc.
30 May 23
9 Meters Biopharma Announces Management Change and Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome
4:11pm
to or arising from any such charge,
complaint or lawsuit filed by Executive or on Executive’s behalf, individually or collectively. In addition, nothing … or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under
8-K
EX-10.2
NMTRQ
9 Meters Biopharma, Inc.
18 Jan 22
9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer
8:05am
to or arising from any such charge, complaint or lawsuit filed by you or on your behalf, individually or collectively.
7.Confidentiality. You acknowledge
8-K
EX-10.4
NMTRQ
9 Meters Biopharma, Inc.
4 May 20
Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC
5:24pm
to monetary damages, attorneys’ fees and/or costs related to or arising from any such charge, complaint or lawsuit filed by Executive or on Executive’s behalf
8-K
EX-10.5
NMTRQ
9 Meters Biopharma, Inc.
4 May 20
Completes concurrent financing of ~$22 million led by Orbimed Advisors, LLC
5:24pm
to monetary damages, attorneys’ fees and/or costs related to or arising from any such charge, complaint or lawsuit filed by Executive or on Executive’s
SC TO-I/A
EX-99
NMTRQ
9 Meters Biopharma, Inc.
28 Feb 20
Issuer tender offer statement (amended)
5:23pm
other than in the Ordinary Course of Business;
(xi) initiate or settle any lawsuit, claim, action, suit, proceeding, investigation or other Legal … of Business;
(x) initiate or settle any lawsuit, claim, action, suit, proceeding, investigation or other Legal Proceeding, whether civil, criminal
8-K
EX-2.1
iaf8rww0
7 Oct 19
Innovate Biopharmaceuticals to Merge with RDD Pharma Creating New Gastroenterology Company Focused on Specialty, Rare and Orphan Diseases
6:59am
8-K
EX-10.1
0nq8xo zz4
1 May 19
Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market
4:48pm
10-K
pklg9ls bs
31 Mar 17
Annual report
12:00am
- Prev
- 1
- Next